The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Methyl-4-amine-5-((4-(((5-(2-amine-4-methylthiazol)-4H-1,2,4-triazol-4-amine-2-yl)thio)methyl)-1H-1,2,3-triazol-1-yl)methyl)pyrimidine ID: ALA3775972
PubChem CID: 127032963
Max Phase: Preclinical
Molecular Formula: C15H18N12S2
Molecular Weight: 430.53
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ncc(Cn2cc(CSc3nnc(-c4sc(N)nc4C)n3N)nn2)c(N)n1
Standard InChI: InChI=1S/C15H18N12S2/c1-7-11(29-14(17)20-7)13-23-24-15(27(13)18)28-6-10-5-26(25-22-10)4-9-3-19-8(2)21-12(9)16/h3,5H,4,6,18H2,1-2H3,(H2,17,20)(H2,16,19,21)
Standard InChI Key: LTPHQSVHMHSSOL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3383 1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -2.7000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 -1.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 -0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 -1.3618 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 -0.2436 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 1.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 0.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0997 2.4249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2115 3.6347 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.8144 5.0092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0510 6.2856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.0508 7.4038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.4233 6.7985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.2717 5.3062 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.7337 8.8707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.8247 9.8828 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-6.1739 11.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6875 11.0329 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4196 9.5570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8565 6.3997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3417 9.0296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.7425 12.2909 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
6 8 1 0
5 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 10 1 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 17 2 0
19 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 22 2 0
18 27 1 0
26 28 1 0
24 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 430.53Molecular Weight (Monoisotopic): 430.1219AlogP: 0.62#Rotatable Bonds: 6Polar Surface Area: 178.15Molecular Species: NEUTRALHBA: 14HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.97CX LogP: -0.42CX LogD: -0.44Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.29Np Likeness Score: -2.34
References 1. He H, Wang W, Zhou Y, Xia Q, Ren Y, Feng J, Peng H, He H, Feng L.. (2016) Rational design, synthesis and biological evaluation of 1,3,4-oxadiazole pyrimidine derivatives as novel pyruvate dehydrogenase complex E1 inhibitors., 24 (8): [PMID:26972920 ] [10.1016/j.bmc.2016.03.011 ]